Pharmaceutical

Express Scripts sues FTC and demands drug pricing report retraction

The company claims that the FTC’s July 2024 report is riddled with “false and misleading claims” about the PBM industry.

Sep 18, 2024 - 04:00
Express Scripts sues FTC and demands drug pricing report retraction
The company claims that the FTC’s July 2024 report is riddled with “false and misleading claims” about the PBM industry.
Read the original article

Tags:

Previous Article

ESMO 2024: Enhertu to eclipse SOC for HER2+ breast cancer with brain metastases

Next Article

FDA lifts partial clinical hold on Zentalis Pharma’s cancer WEE1 inhibitor  

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Keytruda combination treatment for NSCLC falls short in Phase III

Keytruda combination treatment for NSCLC falls short in...

Mar 22, 2024

STAT+: Sophisticated phishing and deepfakes: How generative AI brings new threats for hospitals

STAT+: Sophisticated phishing and deepfakes: How genera...

Jan 30, 2024

Verona Pharma’s ensifentrine inches closer to approval decision in COPD

Verona Pharma’s ensifentrine inches closer to approval ...

Sep 11, 2023